Rigel Pharmaceuticals, Inc.
(NASDAQ:RIGL)|
6.00 -1.42 (-19.14%) Dec 01 - Close |
|
|
|
After-Hours 6.03 +0.03 (0.50%) Mon, 1 Dec 2008 6:50 PM
- Compare RIGL with:
- View: Line | Candlestick
Company Profile
Rigel Pharmaceuticals, Inc.
1180 Veterans Blvd.
South San Francisco, CA 94080
United States - Map
Phone: (650) 624-1100
Fax: (650) 624-1101
Website: www.rigel.com
State of incorporation: Delaware
CEO: James M. Gower
Employees: 159
Sector: Healthcare
Industry Group: Drugs
Industry: Drug Manufacturers - Major
Provider of small-molecule drugs
A clinical-stage drug development company, which discovers and develops novel, small molecule drugs for the treatment of inflammatory/autoimmune diseases, cancer and viral diseases.
Recent news for RIGL
-
Rigel to Present at the Piper Jaffray Annual Health Care Conference
PR Newswire - Nov 25 at 7:30 ET
-
Rigel's R788 Phase 2a Results Published in Arthritis and Rheumatism
PR Newswire - Nov 11 at 7:30 ET
-
Rigel to Present at the 2008 Credit Suisse Healthcare Conference
PR Newswire - Nov 11 at 7:00 ET
-
RIGEL PHARMACEUTICALS INC Financials
EDGAR Online Financials - Nov 08 at 9:04 ET
-
The 10 Biggest Nasdaq Losers of October
Motley Fool - Nov 05 at 4:10 ET
-
New Star Analyst Rankings for RIGEL PHARMACEUTLS
StarMine - Nov 04 at 9:24 ET
-
RIGEL PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report
EDGAR Online - Nov 04 at 8:32 ET
-
Development costs lead to bigger 3Q loss for Rigel
AP - Nov 03 at 4:03 ET
-
Rigel Investor Update Call scheduled for 8:30 am ET today
CCBN - Nov 03 at 8:30 ET
-
EDGAR Online - Nov 03 at 6:07 ET